Ulcerative Colitis (Disorder) Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting ulcerative colitis (disorder) clinical trials across 5 countries. Studies span Not Applicable, Phase 1. Top locations include Hangzhou, Zhejiang, China, Komagane, Nagano, Japan, Los Angeles, California, United States. Updated daily from ClinicalTrials.gov.


Ulcerative Colitis (Disorder) Trials at a Glance

7 actively recruiting trials for ulcerative colitis (disorder) are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Hangzhou, Komagane, and Los Angeles. Lead sponsors running ulcerative colitis (disorder) studies include Benethera (Shaoxing) Biotechnology Co., Ltd., Humanitas Clinical and Research Center, and Assistance Publique Hopitaux De Marseille.

Browse ulcerative colitis (disorder) trials by phase

Treatments under study

About Ulcerative Colitis (Disorder) Clinical Trials

Looking for clinical trials for Ulcerative Colitis (Disorder)? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ulcerative Colitis (Disorder) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ulcerative Colitis (Disorder) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1

A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult

IBD (Inflammatory Bowel Disease)Ulcerative Colitis (UC)CD - Crohn's Disease+2 more
Benethera (Shaoxing) Biotechnology Co., Ltd.68 enrolled1 locationNCT07632573
Recruiting
Not Applicable

Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA

Crohn DiseaseMalnutrition or Risk of MalnutritionIBD+1 more
Lionhealth Srl Società Benefit146 enrolled4 locationsNCT07433946
Recruiting
Not Applicable

Sodium Butyrate and Kluyveromyces Marxianus Supplementation in Inflammatory Bowel Disease

Ulcerative Colitis (Disorder)
University of Padova40 enrolled1 locationNCT07591012
Recruiting
Not Applicable

Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis

Ulcerative Colitis (Disorder)
Showa Inan General Hospital30 enrolled1 locationNCT07243639
Recruiting
Not Applicable

Effects of Pomegranate Juice on Ulcerative Colitis

Ulcerative Colitis (Disorder)
University of California, Los Angeles30 enrolled2 locationsNCT07115862
Recruiting
Not Applicable

Study of Tissue Repair in Inflammatory Bowel Disease Exploiting Organoid Technology

Crohn DiseaseInflammatory Bowel Diseases (IBD)Ulcerative Colitis (Disorder)
Assistance Publique Hopitaux De Marseille60 enrolled1 locationNCT06805890
Recruiting

The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis

Ulcerative Colitis (Disorder)
Humanitas Clinical and Research Center450 enrolled1 locationNCT06691061